Kutluk Oktay, MD, FACOG is one of the world's foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients.
Dr. Oktay conducted key research on ovarian follicle and embryo development, as well as on controlled ovarian stimulation and in vitro fertilization.
Dr. Oktay has devoted his professional life to the science of fertility preservation and infertility treatment. He is a world-renowned researcher, a gifted medical educator, and a skilled clinician dedicated to his patients. Dr. Oktay was invited to the President's Cancer Panel as an expert on fertility issues of cancer patients and fertility preservation. In attestation to his recognition as a leading clinician-scientist in infertility field, he received a highly competitive research grant from the National Institute of Health to study the impact of chemotherapy on fertility of cancer survivors. Furthermore, he was named the co-chair of the American Society of Clinical Oncology Committee for Fertility Preservation Guideline for People with Cancer and served as Consultant Physician at Memorial Sloan-Kettering Cancer Center, and a Consultant for Cancer and Allied Diseases at Memorial Hospital. Dr. Oktay founded and was elected as the first President of the Fertility Preservation Special Interest Group at American Society of Reproductive Medicine.
In 2008, after a 10-year career at the Weill Medical College of Cornell University, Dr. Oktay became a Professor of Obstetrics & Gynecology and the Director of Division of Reproductive Medicine & Infertility at New York Medical College. He then founded the Innovation Institute for Fertility Preservation and IVF (IFPI).